Skip to main content
. 2021 Aug 1;60(15):2367–2374. doi: 10.2169/internalmedicine.6127-20

Figure 2.

Figure 2.

Bar graphs of the relative changes in the E/e’ from baseline to six months after the administration of dapagliflozin, showing that the relative changes in the E/e’ in HFpEF patients with dyslipidemia were significantly larger than those in HFpEF patients without dyslipidemia, although such finding was not observed in non-HFpEF patients. HFpEF: heart failure with preserved ejection fraction